Michael S. Iskra

Insider Reports History

Entity
Individual
Location
C/O Ortho Clinical Diagnostics Holdings, 1001 Route 202, Raritan, NJ
Signature
/s/ Phillip S. Askim, attorney-in-fact for Michael S. Iskra
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael S. Iskra:

Stock Role Class Num Shares Value Price $ Report Date Ownership
QuidelOrtho Corp EVP & CCO Common Stock 16.6K $735K $44.19 Jun 1, 2024 Direct
QuidelOrtho Corp EVP & CCO Restricted Stock Units 3.59K $159K $44.19 Jun 1, 2024 Direct
Ortho Clinical Diagnostics Holdings plc Executive Vice President Ordinary Shares, $0.00001 par value 0 $18.77 May 27, 2022 Direct
Ortho Clinical Diagnostics Holdings plc Executive Vice President Stock Option 0 May 27, 2022 Direct

Insider Reports Filed by Michael S. Iskra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QDEL QuidelOrtho Corp Jun 1, 2024 3 -$57.4K 4 Jun 4, 2024 EVP & CCO
QDEL QuidelOrtho Corp Mar 28, 2024 3 -$85K 4 Apr 1, 2024 Interim CEO, EVP & CCO
QDEL QuidelOrtho Corp Feb 27, 2024 1 $0 4 Feb 29, 2024 Interim CEO, EVP & CCO
QDEL QuidelOrtho Corp Feb 8, 2024 1 $0 4 Feb 12, 2024 EVP & CCO
QDEL QuidelOrtho Corp Jun 1, 2023 3 -$158K 4 Jun 5, 2023 EVP & CCO
QDEL QuidelOrtho Corp Apr 1, 2023 3 -$617K 4 Apr 4, 2023 EVP & CCO
QDEL QuidelOrtho Corp Mar 28, 2023 2 $0 4 Mar 30, 2023 EVP & CCO
QDEL QuidelOrtho Corp Jun 1, 2022 2 $0 4 Jun 3, 2022 Chief Commercial Officer
QDEL QuidelOrtho Corp May 27, 2022 3 $0 4 Jun 1, 2022 Chief Commercial Officer
QDEL QuidelOrtho Corp May 27, 2022 0 $0 3 Jun 1, 2022 Chief Commercial Officer
OCDX Ortho Clinical Diagnostics Holdings plc May 27, 2022 4 $0 4 Jun 1, 2022 Executive Vice President
OCDX Ortho Clinical Diagnostics Holdings plc May 21, 2021 1 $0 4 May 25, 2021 Executive Vice President